BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

Novel Blood Test Enhances Early Detection of Pancreatic Cancer

8 months ago

• A new blood test combining CA199.STRA and CA19-9 biomarkers significantly improves the detection rate of early-stage pancreatic cancer compared to the standard CA19-9 test alone. • The combination test demonstrated a 71% accuracy in identifying pancreatic cancer samples in the lab, a 27% improvement over the 44% accuracy of the CA19-9 test. • Incorporating a protein biomarker called LRG1 alongside CA199.STRA and CA19-9 further enhances the specificity of the test, reducing false positive results. • This multi-biomarker approach underscores the importance of combining different validated biomarkers for more effective and accurate pancreatic cancer detection.